vimarsana.com

Page 79 - சங்கம் ஆஃப் நோய்த்தடுப்பு மேலாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID vaccine education campaigns take targeted approach Here s why

USA TODAY If you ve been waiting for a big national campaign telling you COVID-19 vaccines are safe and everybody should get them, don t hold your breath. Until the supply is plentiful, the federal effort is largely focused on minority communities hesitant about the immunizations. It s a wise approach, experts say.  The kind of one-size-fits-all public service announcements that once blanketed the country won t work for COVID-19 vaccines, they say. Those were for universal messages – only you can prevent forest fires, keep America beautiful, friends don t let friends drive drunk. With COVID-19, different communities need different messages, and mass advertising doesn t necessarily make sense, said Hal Hershfield, a professor of behavioral decision-making at the University of California-Los Angeles Anderson School of Management. 

Kansas struggles to fix vaccine reporting issues

There s no giant national campaign for COVID-19 vaccine education; experts say there s a better way

Dose shortages undermine push by U S states to speed COVID-19 vaccinations

By Carl O Donnell (Reuters) - When the U.S. government began shipping COVID-19 vaccines in December, state health providers could not administer shots fast enough to keep pace with deliveries and millions of doses sat waiting for arms. Two months later, the situation has reversed. Supply constraints are slowing ambitious vaccination programs, as massive sites capable of putting shots into thousands of arms daily in states including New York, California, Florida and Texas, as well as hospitals and pharmacies, beg for more doses. Nearly a dozen state and local officials told Reuters they could vaccinate up to four times more people, but federal vaccine shipments remain frustratingly small. Two months into the vaccine rollout, most states have received enough doses to vaccinate fewer than 10% of their residents. With deliveries based on population, most states receive fewer than a 100,000 doses per week of the Pfizer Inc/BioNTech SE and Moderna Inc vaccines that both require two shots. St

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.